4//SEC Filing
BRADLEY PHARMACEUTICALS INC 4
Accession 0000864268-04-000008
CIK 0000864268operating
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 2:55 PM ET
Size
8.9 KB
Accession
0000864268-04-000008
Insider Transaction Report
Form 4
GLASSMAN BRADLEY
Senior VP - Sales & Marketing
Transactions
- Award
Common Stock
2004-01-07$23.88/sh+1,466$35,008→ 26,810 total
Holdings
- 60,000
Stock Options (Right to buy)
Exercise: $7.05From: 2004-07-09Exp: 2011-07-08→ Common Stock (60,000 underlying) - 15,680(indirect: By 401(k))
Common Stock
- 1,326
Stock Options (Right to buy)
Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (1,326 underlying) - 3,232(indirect: By 401(k))
Common Stock
- 3,305
Stock Options (Right to buy)
Exercise: $8.81From: 2003-07-09Exp: 2004-07-08→ Common Stock (3,305 underlying) - 15,620(indirect: By Trust)
Common Stock
- 12,000
Stock Options (Right to buy)
Exercise: $1.38From: 2003-12-08Exp: 2010-12-07→ Common Stock (12,000 underlying) - 20,880(indirect: By Trust)
Class B Common Stock
Documents
Issuer
BRADLEY PHARMACEUTICALS INC
CIK 0000864268
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000864268
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 2:55 PM ET
- Size
- 8.9 KB